These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23944387)

  • 21. Sildenafil for pulmonary hypertension complicating bronchopulmonary dysplasia.
    Bhatt-Mehta V; Donn SM
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):393-5. PubMed ID: 24866752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
    Ghofrani HA; Voswinckel R; Reichenberger F; Olschewski H; Haredza P; Karadaş B; Schermuly RT; Weissmann N; Seeger W; Grimminger F
    J Am Coll Cardiol; 2004 Oct; 44(7):1488-96. PubMed ID: 15464333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and pharmacodynamics of sildenafil in a patient treated with human immunodeficiency virus protease inhibitors.
    Aschmann YZ; Kummer O; Linka A; Wenk M; Azzola A; Bodmer M; Krähenbühl S; Haschke M
    Ther Drug Monit; 2008 Feb; 30(1):130-4. PubMed ID: 18223477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy and safety of sildenafil therapy in pulmonary artery hypertension: a meta-analysis].
    Kuang TG; Wang J; Zhai ZG; Guo XH; Wang C
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1021-4. PubMed ID: 17672963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphodiesterase 5 inhibitors in vascular systemic disorders.
    Allanore Y
    Joint Bone Spine; 2012 Jul; 79(4):338-40. PubMed ID: 22410367
    [No Abstract]   [Full Text] [Related]  

  • 27. The utility of sildenafil in pulmonary hypertension: a focus on bronchopulmonary dysplasia.
    Wardle AJ; Wardle R; Luyt K; Tulloh R
    Arch Dis Child; 2013 Aug; 98(8):613-7. PubMed ID: 23625986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal trends in use of sildenafil among pediatric patients.
    Bhutta AT; Beam B; Prodhan P
    Am J Respir Crit Care Med; 2013 Nov; 188(10):1269-71. PubMed ID: 24236598
    [No Abstract]   [Full Text] [Related]  

  • 30. Sildenafil plasma concentrations in two HIV patients with pulmonary hypertension treated with ritonavir-boosted protease inhibitors.
    Chinello P; Cicalini S; Pichini S; Pacifici R; Tempestilli M; Petrosillo N
    Curr HIV Res; 2012 Mar; 10(2):162-4. PubMed ID: 22329523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sildenafil for the treatment of pulmonary hypertension in pediatric patients.
    Huddleston AJ; Knoderer CA; Morris JL; Ebenroth ES
    Pediatr Cardiol; 2009 Oct; 30(7):871-82. PubMed ID: 19705181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic therapy for erectile dysfunction and its interaction with the cardiovascular system.
    Ioakeimidis N; Kostis JB
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):53-64. PubMed ID: 24281316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute and long-term efficacy and safety of sildenafil for the treatment of chronic thromboembolic pulmonary hypertension in a heart transplant recipient.
    Zacà V; Padeletti M; Pagliaro A; Furiozzi F; Mondillo S; Favilli R
    Pharmacology; 2011; 87(1-2):24-7. PubMed ID: 21178386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Two-year follow-up of pulmonary arterial hypertension patients treated with sildenafil].
    Franchi SM; Barreto AC; Cícero C; Castro CR; Ribeiro ZV; Lopes AA
    Arq Bras Cardiol; 2010 May; 94(5):671-7. PubMed ID: 20428715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transition of PH patients from sildenafil to tadalafil: feasibility and practical considerations.
    Shlobin OA; Brown AW; Weir N; Ahmad S; Lemma M; Nathan SD
    Lung; 2012 Oct; 190(5):573-8. PubMed ID: 22797830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sildenafil citrate for the treatment of pulmonary hypertension.
    Hrometz SL; Shields KM
    Drugs Today (Barc); 2006 Dec; 42(12):771-84. PubMed ID: 17285150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphodiesterase 5 inhibitors for erectile dysfunction.
    Setter SM; Iltz JL; Fincham JE; Campbell RK; Baker DE
    Ann Pharmacother; 2005; 39(7-8):1286-95. PubMed ID: 15941818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sildenafil for pulmonary hypertension.
    Lee AJ; Chiao TB; Tsang MP
    Ann Pharmacother; 2005 May; 39(5):869-84. PubMed ID: 15827074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension.
    Abman SH; Kinsella JP; Rosenzweig EB; Krishnan U; Kulik T; Mullen M; Wessel DL; Steinhorn R; Adatia I; Hanna B; Feinstein J; Fineman J; Raj U; Humpl T;
    Am J Respir Crit Care Med; 2013 Mar; 187(6):572-5. PubMed ID: 23220921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase III, multicenter, collaborative, open-label clinical trial of sildenafil in Japanese patients with pulmonary arterial hypertension.
    Satoh T; Saji T; Watanabe H; Ogawa S; Takehara K; Tanabe N; Yamada N; Yao A; Miyaji K; Nakanishi N; Suzuki Y; Fujiwara T; Kuriyama T
    Circ J; 2011; 75(3):677-82. PubMed ID: 21304214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.